Propylene glycol Active Not Recruiting Phase 4 Trials for Meibomian Gland Dysfunction (MGD) / Posterior Blepharitis Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01456780Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis